Turkey
Anatolia Geneworks, founded in 2010 in Istanbul, is an established player in the Biotechnology, Medical Devices, and Pharmaceutical industries. Renowned for its Molecular Diagnostics Solutions, the company leverages its expertise in molecular genetics, healthcare, mechanical engineering, and marketing to develop high-quality diagnostic products.
Anatolia's core competencies include designing and manufacturing Real-Time PCR kits, nucleic acid extraction kits, and rapid antigen test kits. The company is among the few globally with the capability to deliver turnkey PCR solutions. Its operations adhere to rigorous standards such as ISO 9001:2015 and ISO 13485:2016.
A publicly traded entity on the Istanbul Stock Exchange since 2021, Anatolia's reach extends internationally through subsidiaries in Germany, the Netherlands, Italy, Poland, Bulgaria, and Pakistan. No recent investment has been reported, indicating a potential opportunity for investors seeking entry into the thriving molecular diagnostics sector.
